Our Experts

At NDA we’re a team of experts – experts in the regulated disciplines, and experts in drug development.

Some of us have attained our experience from working inside regulatory authorities, carefully assessing the benefits and risks of new treatments. Some of us have worked for years in the biotech and pharmaceutical industry, patiently developing life changing products for patients suffering from debilitating and sometimes deadly diseases and conditions.

Whatever our background, we share a passion for the art and science of drug development and for making a difference to the clients and the patients we ultimately serve.

Get to know the people behind the passion – read more about our incredible team below.


Antonella Cominetti

Senior Consultant
Expert in regulatory strategies for the European and Swiss markets

Christian Redondo-Müller

Principal Consultant
Experience in regulatory R&D (clinical efficacy and safety)

Christine Lind

SVP Commercial
Expert in executive leadership, development and business strategy

Daniela Gerl

Principal Consultant
Expert in regulatory strategic advice and project management

Dr Albert L. Kraus

Advisory Board Member 
Expert in in regulatory sciences and global medicine development

Dr Andrea Pless

Principal Consultant
Expert in CMC, drug development and product lifecycle management

Dr Annemarie Ableitner-Kurz

Principal Consultant
Expert in non-clinical development

Dr Björn Carlsson

Director of the Advisory Board
Expert in non-clinical development and ATMPs

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.